News from alimera sciences, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 17, 2018, 17:32 ET Alimera Sciences Announces Nine Clinical Presentations and a Sponsored Symposium at 18th EURETINA Congress

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in commercialization and development of prescription ophthalmic pharmaceuticals, today...

Sep 13, 2018, 16:30 ET Alimera Sciences Announces Three Podium Presentations for ILUVIEN® to be Presented at 2018 Retina Society's Annual Meeting

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today...

Sep 04, 2018, 17:43 ET Alimera Sciences Announces Exchange of Series B Preferred Stock for Newly Issued Series C Preferred Stock

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today...

Aug 29, 2018, 07:30 ET Alimera Sciences to Present at the 20th Annual HC Wainwright Global Investment Conference

Alimera Sciences (NASDAQ: ALIM), a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic ...

Aug 28, 2018, 07:30 ET Alimera Sciences to Present at the Annual B. Riley Healthcare Conference

Alimera Sciences (NASDAQ: ALIM), a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic ...

Jul 30, 2018, 16:30 ET Alimera Sciences Reports Second Quarter 2018 Results

Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company that specializes in the commercialization and development of...

Jul 18, 2018, 07:30 ET Alimera Sciences to Report Second Quarter 2018 Results July 30, 2018

Alimera Sciences (NASDAQ: ALIM), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that...

Jul 11, 2018, 07:30 ET Alimera Sciences Announces 8 ILUVIEN® Presentations At The 2018 American Society Of Retina Specialists Annual Meeting

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today...

Jun 21, 2018, 07:30 ET Alimera Sciences Appoints Mary T. Szela to its Board of Directors

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today...

Jun 11, 2018, 07:30 ET The UK National Institute For Health And Care Excellence To Undertake A Partial Review Of The ILUVIEN Reimbursement Guidance Allowing Broader Availability

Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a pharmaceutical company that specializes in the commercialization and development of prescription ...

Jun 04, 2018, 07:30 ET Alimera Sciences Terminates At-the-Market Offering Agreement

Alimera Sciences (NASDAQ: ALIM), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that...

May 31, 2018, 07:30 ET Alimera Sciences Announces the Reimbursement of ILUVIEN® in Spain

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today...

May 22, 2018, 07:30 ET Alimera Sciences to Present at the 8th Annual LD Micro Invitational Conference

Alimera Sciences (NASDAQ: ALIM), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that...

May 06, 2016, 07:30 ET Alimera Sciences' ILUVIEN® Data Presented At 2016 ARVO

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals,...